Non-smoker exposure to secondhand cannabis smoke. I. Urine screening and confirmation results

Journal of Analytical Toxicology

Volumn 39, Issue 1, 2015, Pages 1-12

  Cone, Edward J ^a   Bigelow, George E ^a   Herrmann, Evan S ^a   Mitchell, John M ^b   LoDico, Charles ^c   Flegel, Ronald ^c   Vandrey, Ryan ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RTI INTERNATIONAL   (United States)

^c SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; DRONABINOL; PASSIVE SMOKING;

ADULT; ARTICLE; CANNABIS SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GAS CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MALE; MASS SPECTROMETRY; PASSIVE SMOKING; ROOM VENTILATION; URINALYSIS; ADVERSE EFFECTS; CHEMISTRY; MASS FRAGMENTOGRAPHY; SENSITIVITY AND SPECIFICITY; SMOKING; SPECIMEN HANDLING; URINE; YOUNG ADULT;

CANNABIS;

ADULT; CANNABIS; DRONABINOL; ENVIRONMENTAL EXPOSURE; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; SENSITIVITY AND SPECIFICITY; SMOKING; SPECIMEN HANDLING; TOBACCO SMOKE POLLUTION; URINALYSIS; YOUNG ADULT;

EID: 84922465578     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bku116     Document Type: Article

References (27)

1. UNODC. World Drug Report 2012. 2012. United Nations publication, Sales No. E.12.XI.1.
2. Arnold, J.C., Boucher, A.A., Karl, T. (2012) The yin and yang of cannabis-induced psychosis: the actions of Delta(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia. Current Pharmaceutical Design, 18, 5113-5130.
3. Swift, W., Wong, A., Li, K.M., Arnold, J.C., McGregor, I.S. (2013) Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile. PLoS One, 8, e70052.
4. Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T.R. et al. (2009) High-potency cannabis and the risk of psychosis. British Journal of Psychiatry, 195, 488-491.
5. Morgan, C.J., Freeman, T.P., Schafer, G.L., Curran, H.V. (2010) Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis. Neuropsychopharmacology, 35, 1879-1885.
6. UNODC.World Drug Report 2013. 2013. United Nations publication, Sales No. E.13.XI.6.
7. Grotenhermen, F. (2003) Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics, 42, 327-360.
8. ElSohly, M.A., Ross, S.A., Mehmedic, Z., Arafat, R., Yi, B., Banahan, B.F., III. (2000) Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980-1997. Journal of Forensic Sciences, 45, 24-30.
9. Office of National Drug Control Policy. National Drug Control Strategy; Data Supplement 2013. 2013. Washington, DC.
10. Cone, E.J., Roache, J.D., Johnson, R.E. Effects of passive exposure to marijuana smoke. In: Anonymous pp. (ed). Problems of Drug Dependence, 1986. U.S. Government Printing Office: Washington, 1986. 150-156.
11. Cone, E.J., Johnson, R.E. (1986) Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke. Clinical Pharmacology & Therapeutics, 40, 247-254.
12. Cone, E.J., Johnson, R.E., Darwin, W.D., Yousefnejad, D., Mell, L.D., Paul, B.D. et al. (1987) Passive inhalation of marijuana smoke: urinalysis and room air levels of delta-9-tetrahydrocannabinol. Journal of Analytical Toxicology, 11, 89-96.
13. Ferslew, K.E., Manno, J.E., Manno, B.R. (1983) Determination of urinary cannabinoid metabolites following incidental to marijuana smoke. Research Communications in Substances of Abuse, 4, 289-300.
14. Law, B., Mason, P.A., Moffat, A.C., King, L.J., Marks, V. (1984) Passive inhalation of cannabis smoke. Journal of Pharmacy and Pharmacology, 36, 578-581.
15. Mason, A.P., Perez-Reyes, M., McBay, A.J., Foltz, R.L. (1983) Cannabinoid concentrations in plasma after passive inhalation of marijuana smoke. Journal of Analytical Toxicology, 7, 172-174.
16. Mule, S.J., Lomax, P., Gross, S.J. (1988) Active and realistic passive marijuana exposure tested by three immunoassays and GC/MS in urine. Journal of Analytical Toxicology, 12, 113-116.
17. Magerl, H., Wiegand, C., Schulz, E. (1987) Cannabinoid intake by passive smoking. Arch Kriminologie, 179, 31-37.
18. Morland, J., Bugge, A., Skuterud, B., Steen, A.,Wethe, G.H., Kjeldsen, T. (1985) Cannabinoids in blood and urine after passive inhalation of cannabis smoke. Journal of Forensic Sciences, 30, 997-1002.
19. Perez-Reyes, M., DiGuiseppi, S., Mason, A.P., Davis, K.H. (1983) Passive inhalation of marijuana smoke and urinary excretion of cannabinoids. Clinical Pharmacology & Therapeutics, 34, 36-41.
20. Niedbala, R.S., Kardos, K.W., Fritch, E.F., Kunsman, K.P., Blum, K.A., Newland, G.A. et al. (2005) Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle. Journal of Analytical Toxicology, 29, 607-615.
21. Rohrich, J., Schimmel, I., Zorntlein, S., Becker, J., Drobnik, S., Kaufmann, T. et al. (2010) Concentrations of delta9- tetrahydrocannabinol and 11-nor-9-carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop. Journal of Analytical Toxicology, 34, 196-203.
22. DHHS. (2008) Mandatory Guidelines for Federal Workplace Drug Testing Programs; Notice. Federal Register, 73, 71858-71907.
23. Grant, I., Atkinson, J.H., Gouaux, B., Wilsey, B. (2012) Medical marijuana: clearing away the smoke. Open Neurology Journal, 6, 18-25.
24. Greydanus, D.E., Hawver, E.K., Greydanus, M.M., Merrick, J. (2013) Marijuana: Current Concepts. Front Public Health, 1, 42.
25. Grotenhermen, F., Muller-Vahl, K. (2012) The therapeutic potential of cannabis and cannabinoids. Dtsch. Arztebl. Int., 109, 495-501.
26. Law, B., Mason, P.A., Moffat, A.C., Gleadle, R.I., King, L.J. (1984) Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin. Journal of Pharmacy and Pharmacology, 36, 289-294.
27. Kelly, P., Jones, R.T. (1992) Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users. Journal of Analytical Toxicology, 16, 228-235.